Assignee
ARMAGEN TECHNOLOGIES INC
US·4 granted patents·2 pending applications·156 citations·filing 2005–2014
Top patents by PatentIndex Score
6 records- 0197US7741446B2Fusion antibodies that cross the blood-brain barrier in both directionsARMAGEN TECHNOLOGIES INC·Filed 2007·Granted Jun 22, 2010·83 cites·17 claims
- 0295US8053569B2Nucleic acids encoding and methods of producing fusion proteinsARMAGEN TECHNOLOGIES INC·Filed 2005·Granted Nov 8, 2011·36 cites·58 claims
- 0394US8715661B2Methods and compositions for increasing arylsulfatase A activity in the CNSARMAGEN TECHNOLOGIES INC·Filed 2013·Granted May 6, 2014·20 cites·26 claims
- 0493US8920801B2Methods and compositions for increasing arylsulfatase A activity in the CNSARMAGEN TECHNOLOGIES INC·Filed 2014·Granted Dec 30, 2014·17 cites·20 claims
- 0564US2014193409A1Fusion proteins for delivery of gdnf to the cnsARMAGEN TECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 0658US2015023956A1Methods and compositions for increasing enzyme activity in the cnsARMAGEN TECHNOLOGIES INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ARMAGEN TECHNOLOGIES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →